CD276 and non-small cell lung carcinoma: A meta-analysis conducted by Wu S. et al., encompassing a total of 864 NSCLC patients, suggested a lack of significant impact of B7-H3 expression on overall survival rates, highlighting the need for further research to elucidate the relationship between B7-H3 and patient prognosis in NSCLC [120].